Schizophrenia Flashcards
what is Schizophrenia?
chronic, severe, debilitating mental illness characterized by disordered
thoughts, abnormal behaviours, and anti-social behaviours.
what type of disorder ?
is a psychotic disorder, where a person with schizophrenia does not identify with reality at times (APA).
Features of Schz
- McGrath et al. (2008) - Schizophrenia affects about 1.1% of the world’s population.
- Women tend to be diagnosed later in life than men. Modal age of onset is between 18 - 25 for men and between 25 - 35 for women, with a second peak occurring around menopause.
- It affects men 1.5 times more than women.
- Tandon et al (2009) - Schizophrenia is broadly characterized by three core symptoms: positive symptoms, negative symptoms, and cognitive dysfunction.
Phases of Schz
PAR
- Prodromal. This early stage is often not recognized until after the illness has progressed.
- Active. Also known as acute schizophrenia, this phase is the most visible. People will show the tell-tale symptoms of psychosis, including hallucinations, suspiciousness, and delusions.
- Residual. Though not a recognized diagnosis in the DSM-5, this term may still be used to describe a time when individuals with schizophrenia have fewer obvious symptoms (the psychos is is muted). However some symptoms are still present.
Biological exp of schz
What is Dopamine?
a neurotransmitter that regulates mood and attention.
- High dopamine activity leads to acute episodes of sch and positive symptoms (delusions, hallucinations, confused thinking).
- Low dopamine activity leads to negative symptoms (avolition, speech poverty).
What does the Dopamine Hypothesis (Van Rossum, 1967; Carlsson, 1970s) state?
- schizophrenia is caused by too much dopamine transmission, or increased dopamine (D2) receptors, in key areas of the brain.
- This causes the neurons that use dopamine to fire too often and transmit too many messages.
Evidence/strengths of The Dopamine Hypothesis (Van Rossum,
1967; Carlsson, 1970s)
Owen et al (1987)- autopsies have found a large number of dopamine receptors and an increase in the amount of dopamine in the left amygdala (Falkai et al., 1988).
Antipsychotic drugs, dopamine antagonists, block the activity of dopamine in the brain and eliminate symptoms such as hallucinations and delusions.
Evidence/limitations of The Dopamine Hypothesis (Van Rossum,
1967; Carlsson, 1970s)
+ This description is too simplistic - it failed to identify any specific brain areas where this would occur. Different dopamine receptors have different brain distributions, so more regional specificity is required.
+Davis et al. (1991)- Dopamine elevation is not universally higher in the brain. There are low levels of dopamine in pre-frontal area (negative symptoms) and higher levels of dopamine in subcortical areas (positive symptoms). This explains how dopamine causes both positive and negative symptoms.
Davis’ Dopamine Hypothesis (version two) 1991
- schizophrenia presents itself after an increase in sub-cortical dopamine, especially in the striatum with the D2 receptor.
- It suggests that abnormalities in the prefrontal cortex, such as an abnormal volume of grey matter, may have caused the abnormalities in the limbic system.
HYPOdopaminergia
Dopamine function in the mesocortical pathway may be responsible for the negative symptoms.
HYPOdopaminergia - Aim of treatment
increase neurotransmission
HYPERdopaminergia
Dopamine systems in the mesolimbic pathway contribute to the positive symptoms.
HYPERdopaminergia- Aim of treatment
slow down neurotransmission
Davis’ Dopamine Hypothesis (version two) 1991Evidence
- Davis et al. (1991) - Postmortem studies have shown high dopamine concentrations in various subcortical brain regions and greater than normal DA receptor densities in the brains of schizophrenic patients.
- Millan et al. (2014) - a decrease in grey matter volume of the temporal lobe has been associated with negative symptoms.
Davis’ Dopamine Hypothesis (version two) 1991 - Evaluation
- This version was still deemed to be over simplified and biologically reductionist.
- Much of the evidence for version two has come from animal lesion or post-mortem studies which means that it has been indirectly collated.
- Findings cannot be generalised to humans as we cannot assume that the dead or animal brains will react to damage in the same way as living human brains.
Further advancements led to a third version of the dopamine hypothesis (Howes and Kapur, 2009).
What had been identified?
identified that most schizophrenics have abnormally high presynaptic dopamine
production in their striatum due to also tending to have 10-20% higher levels, than usual, of D2 receptors there.
third version of the dopamine hypothesis (Howes and Kapur, 2009) - Evidence
Brunello (1995) - D2 receptor occupancy linked to the development of psychosis was confirmed with the evidence from living schizophrenic human brains not just from the deceased or animals.
-Howes and Kapur (2009)-PETstudies show reduced cerebral blood flow in
frontal cortex that provides evidence of regional brain dysfunction in
schizophrenia.
Evaluation of the Dopamine Hypothesis
- Haracz (1982) — postmortem of sch and found elevated dopamine levels in those who had received antipsychotic drugs before death. Those who had not received medication showed normal levels. (However, only correlational).
- Farde et al. (1990) found no difference between schizophrenics’ levels of dopamine compared with ‘healthy’ individuals.
- biologically deterministic. If the individual does have excessive amounts of dopamine then does it really mean that they will develop schizophrenia?
- Biologically reductionist as it oversimplifies the biology involved in the transmission of dopamine and does not take individual differences such as patients’ genetics and hormones into consideration.
Conclusion of dopamine hypothesis
To understand schizophrenia and its causes more thoroughly we must consider the extensive role that our environment plays.
It must be acknowledged that our behaviour and experiences may lead to
abnormalities, as identified in the Diathesis Stress Model. In addition, aetiological validity should be considered, i.e., for a diagnosis to be valid, all patients diagnosed as schizophrenic should have the same cause for their disorder. This is not the case with schizophrenia: The causes may be one of biological or psychological or both.
treatment
What is Drug therapy?
biological treatment for schizophrenia.
Why are Antipsychotic drugs used?
to reduce the intensity of symptoms (particularly positive symptoms).
How do Antiphsychotic drugs work ?
- work by binding to the dopamine receptor sites better than dopamine.
- When dopamine tries to bind with the receptor site, it finds that the site has already been filled by the drugs.
-The reduces the number of receptors that are activated and reduces the effect of dopamine.
What are the First-generation Antipsychotics called?
Typical antipsychotics, e.g., chlorpromazine.
When are Typical antipsychotic drugs used?
to reduce the intensity of positive symptoms, blocking dopamine receptors in the synapses of the brain and thus reducing the action of dopamine.
- They arrest dopamine production by blocking the D2 receptors in synapses that
absorb dopamine, in the mesolimbic pathway thus reducing positive symptoms,
such as auditory hallucinations.
What are the newer drugs called?
atypical antipsychotics, e.g., Risperidone and Clozapine,
What do the atypical antipsychotics target?
D2 dopamine activity in the limbic system. They bind to dopamine,
serotonin, and glutamate receptors. They generally have fewer side effects, e.g.,
less effect on motor movement.
Lobos (2010)
Wang (2013)
- Lobos (2010) - Clozapine is the only atypical antipsychotic that is effective for the management of positive and negative symptoms — it is used after other medication does not work due to serious risk - life-threatening hepatoxicity (liver damage).
- Wang (2013) - Atypical antipsychotic drugs work on negative symptoms,
improving mood, cognitive functions and reducing depression and anxiety. This
involves regulating monoamine, glutamate, gamma-aminobutyric acid (GABA),
cortisol, and neurotrophic factors.
Drug Therapy Evaluation
Benefits
- Antipsychotic medications have greatly improved treatment. Medications reduce positive symptoms particularly hallucinations and delusions; and usually allow the patient to function more effectively and appropriately.
- Thornley et al. carried out a meta-analysis comparing the effects of Chlorpromazine to placebo conditions and found chlorpromazine to be associated with better overall functioning — Drug therapy is an effective treatment for Sch.
- Offering drugs can lead to an enhanced quality of life as patients are given independence ~> Positive impact on the economy as patients can return to work and no longer need to be provided with institutional care.